The Ketamine Research Institute Mini-Fellowship provides didactic, supervised hands-on clinical, and experiential training in ketamine infusion therapy. The program combines three intensive days of training with 12 months of professional guidance and mentoring.
Dates not announced
12 months
This advanced program covers precision medicine-based ketamine therapy, target-controlled infusion methodology, pharmacokinetics, individualized dosing, genetic and laboratory-guided adjustments, adverse-effect mitigation, and patient safety. It includes evidence-based didactics, supervised clinical experience, and a supervised personal ketamine infusion to support a patient-centered understanding of treatment. The program is designed for clinicians seeking to establish or optimize ketamine therapy services, including MDs, DOs, NPs, and CRNAs. Participants receive protocols, evaluation templates, safety checklists, standard operating procedures, and a pharmacokinetic dosing calculator. The practical component consists of three intensive days at the institute's infusion center, followed by 12 months of clinical consultations, business guidance, and mentorship. Graduates earn KRI certification and are listed in the institute's national clinician directory.
Many programs teach the basics. Few prepare you for real-world complexity. Most rely on outdated, standardized dosing protocols that lead to suboptimal outcomes—where fewer than 40% of patients improve, and up to 8% worsen. We teach a different approach: individualized, precision-based care informed by pharmacokinetics, metabolism, comorbidities, and real-time clinical observation.
The Ketamine Research Institute is a US-based clinical research organization developing precision medicine approaches to ketamine infusion therapy, studying optimized dosing protocols to treat depression and offering clinician training in evidence-based ketamine practice.
View all Ketamine Research Institute coursesMany programs teach the basics. Few prepare you for real-world complexity. Most rely on outdated, standardized dosing protocols that lead to suboptimal outcomes—where fewer than 40% of patients improve, and up to 8% worsen. We teach a different approach: individualized, precision-based care informed by pharmacokinetics, metabolism, comorbidities, and real-time clinical observation.
Format: Hybrid. Time commitment: 12 months.
This listing does not have a public price yet. Check the provider website for current tuition, fees, or application-based pricing.
The listing includes a certificate signal. Accreditation note: APA. Confirm credential eligibility directly with the provider before enrolling.
This active course does not have a listed upcoming cohort date yet. Check the provider website for current schedule details.
The current listing status is Active. Use the provider website for the latest enrollment status.
By Ketamine Research Institute
Shares course skills and categories
The Ketamine Research Institute Mini-Fellowship provides psychiatrists with ketamine infusion training, including evidence- and experience-based instruction, supervised hands-on clinical practice, and individualized treatment approaches. The program includes three intensive days at an infusion center followed by 12 mon
Dates not announced
By Ketamine Academy
Shares course skills and categories
Online ketamine therapy training for healthcare professionals, with separate business-focused and clinical-only options. The program covers safe subanesthetic ketamine therapy, clinic setup, and practical forms and protocols for implementation.
Dates not announced
Source lists: 30 hours
Delivery: Online
No medicine self-experience listed
By Ketamine Academy
Shares course skills and categories
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Self-paced access
Delivery: Self-paced + Online
No medicine self-experience listed